We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.9B
AUM Growth
+$1.29B
(+3%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$229M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$212M |
| 3 |
Snowflake
SNOW
|
+$211M |
| 4 |
Lam Research
LRCX
|
+$193M |
| 5 |
CME Group
CME
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$282M |
| 2 |
PepsiCo
PEP
|
+$239M |
| 3 |
Walmart Inc
WMT
|
+$236M |
| 4 |
General Motors
GM
|
+$223M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Pyxis Oncology
PYXS
$247M
| $317K | ﹤0.01% |
+95,703
| New | +$402K |
|
2527
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.39B
| $317K | ﹤0.01% |
+3,500
| New | +$317K |
|
2528
Fresenius Medical Care
FMS
$12.5B
| $316K | ﹤0.01% |
16,552
-125,155
| -88% | -$2.55M |
|
2529
Harbor Long-Term Growers ETF
WINN
$1.17B
| $314K | ﹤0.01% |
12,400
-3,200
| -21% | -$75.8K |
|
2530
Sabra Healthcare REIT
SBRA
$5.23B
| $313K | ﹤0.01% |
+20,330
| New | +$290K |
|
2531
Verrica Pharmaceuticals
VRCA
$83.7M
| $312K | ﹤0.01% |
4,279
+1,770
| +71% | +$136K |
|
2532
Arhaus
ARHS
$1.31B
| $312K | ﹤0.01% |
18,404
-332,050
| -95% | -$5.38M |
|
|
ETW
2533
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.06B
| $311K | ﹤0.01% |
37,617
+24,051
| +177% | +$195K |
|
2534
Latham Group
SWIM
$824M
| $310K | ﹤0.01% |
102,447
+20,836
| +26% | +$72.6K |
|
2535
FIGS
FIGS
$2.53B
| $310K | ﹤0.01% |
+58,155
| New | +$297K |
|
2536
PRA Group
PRAA
$759M
| $309K | ﹤0.01% |
+15,708
| New | +$361K |
|
2537
InMode
INMD
$869M
| $309K | ﹤0.01% |
+16,916
| New | +$311K |
|
2538
iShares US Basic Materials ETF
IYM
$1.04B
| $308K | ﹤0.01% |
2,200
-1,900
| -46% | -$273K |
|
2539
Movado Group
MOV
$772M
| $308K | ﹤0.01% |
12,390
-80,735
| -87% | -$2.11M |
|
|
DEC
2540
Diversified Energy Company
DEC
$1.05B
| $306K | ﹤0.01% |
+22,696
| New | +$316K |
|
2541
TFS Financial
TFSL
$4.95B
| $306K | ﹤0.01% |
+24,254
| New | +$305K |
|
2542
Genesco
GCO
$390M
| $306K | ﹤0.01% |
11,834
-6,330
| -35% | -$166K |
|
|
OPI
2543
DELISTED
Office Properties Income Trust
OPI
| $304K | ﹤0.01% |
149,252
-288,869
| -66% | -$628K |
|
2544
Inovio Pharmaceuticals
INO
$129M
| $304K | ﹤0.01% |
37,598
+17,337
| +86% | +$182K |
|
2545
PCB Bancorp
PCB
$388M
| $303K | ﹤0.01% |
18,609
-2,100
| -10% | -$32.1K |
|
|
RAPP
2546
Rapport Therapeutics
RAPP
$2.37B
| $302K | ﹤0.01% |
+13,000
| New | +$301K |
|
2547
Stepan Co
SCL
$1.41B
| $302K | ﹤0.01% |
+3,600
| New | +$307K |
|
2548
Mistras Group
MG
$608M
| $301K | ﹤0.01% |
36,250
+22,718
| +168% | +$199K |
|
2549
Upland Software
UPLD
$14M
| $300K | ﹤0.01% |
12,044
-2,068
| -15% | -$54.4K |
|
2550
Information Services Group
III
$241M
| $299K | ﹤0.01% |
101,738
-15,739
| -13% | -$52.9K |
|
Similar funds
John Overdeck's Q2 2024 Portfolio in Review
As of Q2 2024, John Overdeck held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
- John Overdeck added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
- John Overdeck's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
- John Overdeck fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
- John Overdeck opened 479 new positions and closed 480 in Q2 2024.
- John Overdeck's portfolio value rose 3% quarter-over-quarter to $43.9B.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.